10-Q: Body and Mind Inc. Reports Q3 2024 Results, Revenue Up Slightly Amidst Strategic Shifts

Body and Mind Inc. reports a slight increase in revenue for the third quarter of 2024, while navigating strategic asset sales and ongoing legal challenges.

Summary

• Body and Mind Inc. reported a revenue of $4.4 million for the three months ended April 30, 2024, a slight increase from $4.17 million in the same period last year.
• The company's gross profit was $1.96 million, compared to $1.93 million in the prior year's quarter.
• Operating expenses were $3.3 million, a slight increase from $3.2 million in the same period last year.
• The net loss from continuing operations was $2.55 million, compared to a loss of $1.83 million in the prior year's quarter.
• The company reported a net loss of $2.54 million, which includes a net income from discontinued operations of $11,511.
• For the nine months ended April 30, 2024, revenue was $13.39 million, compared to $13.24 million in the same period last year.
• The net loss for the nine-month period was $2.54 million, which includes a net income from discontinued operations of $5.22 million.
• The company's cash reserves decreased to $291,543 as of April 30, 2024, from $1.46 million at the end of the previous fiscal year.
• The company had a working capital deficit of $5.4 million as of April 30, 2024.

Sentiment

Score: 4

Explanation: The document presents mixed results with a slight revenue increase but significant net losses and a concerning cash position. The ongoing legal issues and strategic shifts add to the uncertainty, resulting in a negative sentiment overall.

Positives

• The company experienced a slight increase in revenue for both the quarter and nine-month period.
• The company's gross profit increased for both the quarter and nine-month period.
• The company fully repaid a $6.66 million loan during the nine months ended April 30, 2024.
• The company reported a net income from discontinued operations of $5.22 million for the nine-month period.

Negatives

• The company's cash reserves decreased significantly to $291,543 as of April 30, 2024.
• The company reported a working capital deficit of $5.4 million as of April 30, 2024.
• The company experienced a net loss from continuing operations of $2.55 million for the quarter and $7.77 million for the nine-month period.
• The company is involved in ongoing legal proceedings related to a convertible loan agreement.

Risks

• The company faces ongoing legal challenges related to a convertible loan agreement, which could impact its financial position.
• The company's cash reserves have decreased significantly, raising concerns about liquidity.
• The company has a working capital deficit of $5.4 million, which may require additional financing.
• The company's ability to achieve profitability is uncertain given the net losses from continuing operations.

Future Outlook

The company anticipates that current operations, cash on hand and working capital will ensure coverage for all expenses associated with current operations for at least the next 12 months from the issuance of these financial statements. Management believes that the Company has access to capital resources through potential public or private issuances of debt or equity securities to further contribute to the growth of the company.

Management Comments

• Management believes that the Company has access to capital resources through potential public or private issuances of debt or equity securities to further contribute to the growth of the company.

Industry Context

The company operates in the cannabis industry, which is subject to evolving regulations and market conditions. The company's strategic shifts, including asset sales and focus on limited license jurisdictions, reflect the competitive landscape and the need to optimize operations.

Comparison to Industry Standards

• The company's revenue growth is modest compared to some larger multi-state operators in the cannabis industry.
• The company's net losses are significant, indicating challenges in achieving profitability, which is a common issue for many cannabis companies in the growth phase.
• The company's cash position is weak compared to industry leaders, which may limit its ability to pursue growth opportunities.
• The company's strategic shift towards asset sales and limited license jurisdictions is a common strategy among smaller cannabis companies to focus resources and improve profitability.

Legal Proceedings

• Comprehensive Care Group LLC and Susan Williams filed a complaint for declaratory judgement against Body and Mind Inc., Nevada Medical Group LLC., DEP Nevada Inc. and Big Stone Farms AR 1.
• Body and Mind Inc., Nevada Medical Group LLC., DEP Nevada Inc. and Big Stone Farms AR 1 filed a complaint for declaratory judgement and counterclaim against Comprehensive Care Group LLC, Susan Williams, Donald J Marshall, Valecia Ootsey-Walker and Robert DeBin.

Related Party Transactions

• The company has related party transactions with entities controlled by the President, Chief Executive Officer, Chief Financial Officer, and former Corporate Secretary.
• The company entered into a merger agreement with CraftedPlants NJ Corp., an entity controlled by a director of the company.
• The company has a convertible debenture financing with entities controlled by a director of the company.
• The company sold 5% of the outstanding shares of BaM Body and Mind Dispensary NJ, Inc. to an individual who resides in New Jersey and entered into a consulting agreement with the same individual.

Stakeholder Impact

• Shareholders may be concerned about the company's net losses and declining cash reserves.
• Employees may be affected by the company's strategic shifts and asset sales.
• Customers may experience changes in product availability or store locations due to the company's strategic shifts.
• Suppliers and creditors may be impacted by the company's financial challenges and potential need for additional financing.

Next Steps

• The company will continue to pursue strategic asset sales.
• The company will continue to work on obtaining final state licensure in New Jersey.
• The company will continue to defend itself against legal claims.
• The company will continue to monitor and manage its financial risks.

Key Dates

Keywords

cannabis, financial results, revenue, net loss, discontinued operations, convertible loan, legal proceedings, liquidity, working capital, asset sales